UPDATED: St. Jude recalling some defibrillator leads due to damaged insulation

Last year St. Jude Medical agreed to pay $14.25 million to settle 950 pending legal claims related to its riata defibrillator leads. So news of a Class 1 recall of 447 Optisure defibrillator leads due to a manufacturing defect that may have introduced damage to the wires' insulation is rather unsettling.

Mayo Clinic dispatches UV-emitting robots to fight drug-resistant bacteria

With superbug infections proliferating at U.S. healthcare facilities, hospitals are looking for new ways to eliminate potentially deadly bacteria. Mayo Clinic is jumping on the bandwagon, rolling out bacteria-fighting robots that use UV light to kill C. difficile.

Video game neuro therapy company Akili Interactive raises $30M+

Med tech's tentacles continue to extend to new arenas, as evidenced by the $30.5 million funding round for Akili Interactive, which is developing a video game-based platforms for treating ADHD and other neurological conditions in hopes of a product launch in 2017.

FDA nod for synchronized motion table for Intuitive Surgical robotic surgical system

Robotic surgery adherents will soon have a novel option--a table that can move with an Intuitive Surgical robot during a surgical procedure. The idea is to enable surgeons to use gravity to their advantage by moving the table in tandem with a surgical robot to manipulate the patient's body for better surgical access or to remove some of the physical pressure from a certain bodily location.

Former banker faces criminal charges for tips on $12B BD-CareFusion deal

A former Perella Weinberg Partners investment banker faces criminal insider trading charges for informing his father of Becton Dickinson's deal to purchase CareFusion for $12.2 billion in 2014.

J&J signs pledge to combat antimicrobial resistance at Davos summit

Johnson & Johnson is one of more than 80 companies and organizations to sign the Declaration on Combating Antimicrobial Resistance, which was launched at the annual gathering of global bigwigs in Davos, Switzerland.

U.S. pivotal trial starts for Senseonics glucose monitor implant with data due in June

Upstart Senseonics expects to be the first to introduce a long-term implant to continuously monitor glucose levels in diabetics. It's already under review for a CE mark after disclosing pivotal European data in October. Now, it's detailed the plans for the pivotal U.S. study of its Eversense Continuous Glucose Monitoring System.

Top Boston Sci exec says more women are needed in device clinical trials

Dr. Ken Stein, the chief medical officer of Boston Scientific's rhythm management division, said that industry and the healthcare system are not doing a good job of ensuring women are adequately treated with cardiology devices like pacemakers and implantable defibrillators.

Study finds Masimo respiratory monitor more useful in tracking IV patients

Longtime oxygen monitor leader Masimo is touting a study that found its acoustic respiration rate as measured by its Rainbow Acoustic Monitoring is more effective at monitoring dental patients who are under intravenous anesthesia than conventional capnography.

BioMérieux's bioTheranostics unit embarks on solo act with $32M in tow

BioMérieux subsidiary bioTheranostics has had a nice ride at the French company, gaining momentum for its cancer diagnostic tests and generating some growth along the way. But now bioTheranostics is ready to embark on its next chapter, and for this one, it's riding solo.


Pelvalon launches vaginal insert for nonsurgical treatment of fecal incontinence

Sunnyvale, CA's Pelvalon announced the launch of its vaginal insert for bowel control following November's 510(k) clearance of the device, which is easily installed by the patients, eliminating the need for surgery or an in-office procedure.

GSK, Qualcomm rumored to form $1B med tech JV

GlaxoSmithKline and Qualcomm are in talks to create a joint venture to enable GSK to expand into med tech, according to a report by Bloomberg that cites anonymous people knowledgeable of the matter.

Dx Digest: Cepheid lends molecular Dx to MedImmune for infectious disease drug trials; MDxHealth makes strides in liquid biopsy

In this week's Dx Digest, Cepheid teamed up with AstraZeneca's MedImmune and an antimicrobial resistance program sponsored by Europe's Innovative Medicines Initiative to develop quick diagnostic tests for infectious diseases to be used in MedImmune's clinical trials of antibodies. Ireland's HiberGene Diagnostics reeled in €1.5 million ($1.6 million) to fuel marketing for its rapid infectious disease tests. And MDxHealth charted progress for its liquid biopsy test.

Johns Hopkins developing thought-control robotic arm with help of wearable armband

Johns Hopkins University is developing a prosthetic arm that can be controlled by thought.

Researchers get stem cells to 'beat' with electrical current, offering hope for heart regeneration

Columbia engineering researchers have found that electrical stimulation of human heart muscle cells, or cardiomyocytes, engineered from human stem cells can beat with electrical stimulation. For the first time, they found that this activity actually encouraged the nascent cardiomyocytes to beat autonomously and to transfer that to surrounding cardiomyocytes.

Spanish researchers prototype robotic arm for shoulder rehabilitation

Researchers at the Centre for Automation and Robotics at the Universidad Politécnica de Madrid in Spain say they have developed a robotic exoskeleton for rehabilitation from shoulder injuries.

IBM bets its future on machine learning and Watson Health

IBM is the largest analytics provider in the world, with nearly $18 billion in revenues last year. Watson Health, which launched last April and is based on the machine-learning capabilities of supercomputer Watson, is its top initiative to keep that growing. Watson Health is built on the combination of a trio of acquisitions with IBM's own existing analytics capabilities.

Scripps trial finds digital health devices don't improve healthcare use or outcomes

At the annual AdvaMed convention, Dr. Eric Topol of the Scripps Research Institute laid out his vision of a healthcare future dominated by mobile patient monitors and real-time sensors. Alas, a 160-patient, 6-month randomized controlled trial by Topol and others found little evidence of economic benefit as a result of interventions with mobile devices.

Automated external defibrillators rarely used to treat cardiac arrest in high-rise buildings: Study

Automated external defibrillator devices can often mean the difference between life and death for individuals who experience cardiac arrest. But in some cases the products are rarely used, according to a new study.

Medtronic to pony up funds in $525M IRS tax settlement

Medtronic inherited Covidien's tax-friendly Irish domicile last year after the companies finalized their $50 billion merger. But the devicemaker also picked up a tax scuffle from Covidien's former parent company, and now, Medtronic is laying that battle to rest in the form of a $525 million settlement.